Chromogranin A in Tumors: More Than a Marker for Diagnosis and Prognosis
Journal:
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Volume:
4
Page:
161-168
Author(s):
Angelo Corti and Elisabetta Ferrero
Antitumor Pharmacology - Quo Vadis ?
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
4
Page:
389-391
Author(s):
Christian Bailly, Jean-Marc Barret and Anna Kruczynski
Antifolates - Past, Present and Future
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
4
Page:
405-410
Author(s):
Aleem Gangjee and Hiteshkumar D. Jain
Monoclonal Antibodies in Cancer Therapy
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
4
Page:
411-414
Author(s):
Barbara Gatto
Novel Molecular Targets in Cancer Chemotherapy Waiting for Discovery
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
4
Page:
421-423
Author(s):
Conrad Kunick
Optimizing Target Selection and Development Strategy in Cancer Treatment; The Next Wave
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
4
Page:
445-447
Author(s):
Edward A. Sausville
Novel Oncogenic Protein Kinase Inhibitors for Cancer Therapy
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
4
Page:
449-455
Author(s):
Tomi K. Sawyer
Novel Strategies in Cancer Therapeutics: Targeting Enzymes Involved in Cell Cycle Regulation and Cellular Proliferation
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
403-424
Author(s):
M. C. Liu, J. L. Marshall and R. G. Pestell
Antiandrogens in Prostate Cancer Endocrine Therapy
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
455-461
Author(s):
Z. Culig, G. Bartsch and A. Bartsch
Deoxyribozymes as Inhibitors of Vascular Smooth Muscle Cell Growth
Journal:
Current Pharmaceutical Biotechnology
Volume:
5
Page:
337-339
Author(s):
Levon M. Khachigian